New: 🚨
Research Desk in Deutsch. Same sourced, no-hype articles. Now in two languages.
Neu: 🚨
Unser Research Desk gibt es jetzt auf Deutsch. 🇩🇪 Quellenbasierte Artikel zu Retatrutid, Tirzepatid und dem Lesen eines COA, ohne Marketing-Sprache.
Can everyone say Guten abend?
Insane amount of orders taking advantage of our Halloween sale still being active.
Yes we will still fulfil them.
Sale live until 12pm midnight tonight.
🚨 SEMAX
THE RUSSIAN BRAIN PEPTIDE JUST APPROVED FOR COMPOUNDING IN THE UNITED STATES.
Semax is a synthetic heptapeptide, a seven-amino-acid chain (Met-Glu-His-Phe-Pro-Gly-Pro).
It was developed in Russia in the 1980s as a modified fragment of ACTH, with a Pro-Gly-Pro tail added to make it more stable.
It has mainly been studied in laboratory and animal models, where researchers look at its effects on neurotrophic factors such as BDNF and on neuronal signaling. In Russia it has already been approved as a drug. However in Europe this is still for research use only.
@ChrisWillx Will be interesting to see the RUO space as this becomes a main stream telehealth wise.
Heck, we as RUO might have better testing and production than the pharmacy, but we’re not “pharmacies”.
Either way. The future will be interesting
👻 5 Spookiest things about a peptide seller in honor of Halloween 🎃
No HPLC report 💀
No batch number 😱
No verify key 👹
purity claims with no document, and mismatched labels. 🫣
At null. we offer all of these. No need to fret.
On today’s episode of show the report
Semax : The Russian brain peptide just approved for compounding in the United States
Don’t worry Europe. We’ve got you.